Floatz logo

Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine

Gliosarcoma

Jonsson Comprehensive Cancer CentervaccinePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

39 Active assets in the Gliosarcoma cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Mayo Clinic
Phase 2BB
(+)-VINCRISTINE
RTOG Foundation, Inc.
Phase 3BB
Rindopepimut
Celldex Therapeutics
Phase 3BB
DEXAMETHASONE
Pediatric Brain Tumor Consortium
Phase 2BB
Ipilimumab
University College, London
Phase 2/3BB

View all 50 →

Same molecule, other indications

Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine is also rated in:

anaplastic astrocytomaDormant
B
Indicative ·
57 / 100
View asset →
anaplastic oligoastrocytomaDormant
B
Indicative ·
57 / 100
View asset →
gliomaDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →